Page last updated: 2024-10-16

carnitine and HIV Wasting Syndrome

carnitine has been researched along with HIV Wasting Syndrome in 1 studies

HIV Wasting Syndrome: Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. (From Harrison's Principles of Internal Medicine, 13th ed, p1611).

Research Excerpts

ExcerptRelevanceReference
"The objective of this pilot study was to assess the effect of L-carnitine on the course of the HIV-associated lipodystrophy syndrome."7.71L-Carnitine in the treatment of HIV-associated lipodystrophy syndrome. ( Mauss, S; Schmutz, G, 2001)
"The objective of this pilot study was to assess the effect of L-carnitine on the course of the HIV-associated lipodystrophy syndrome."3.71L-Carnitine in the treatment of HIV-associated lipodystrophy syndrome. ( Mauss, S; Schmutz, G, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mauss, S1
Schmutz, G1

Other Studies

1 other study available for carnitine and HIV Wasting Syndrome

ArticleYear
L-Carnitine in the treatment of HIV-associated lipodystrophy syndrome.
    HIV medicine, 2001, Volume: 2, Issue:1

    Topics: Body Weight; Carnitine; Cholesterol, LDL; HIV Wasting Syndrome; Humans; Lipodystrophy; Pain Measurem

2001